Explore
Trendline
Immutep Faces Securities Class Action Over Discontinued Cancer Trial
Immutep Faces Securities Class Action Over Discontinued Cancer Trial
Read More
Trendline
Immutep Faces Securities Class Action Over Misleading Trial Data
Immutep Faces Securities Class Action Over Misleading Trial Data
Read More
Trendline
Faruqi Faruqi, LLP Alerts Gossamer Bio Investors of Class Action Deadline Following Study Results
Faruqi Faruqi, LLP Alerts Gossamer Bio Investors of Class Action Deadline Following Study Results
Read More
Trendline
Rosen Law Firm Urges Immutep Investors to Join Securities Class Action Before Deadline
Rosen Law Firm Urges Immutep Investors to Join Securities Class Action Before Deadline
Read More
Trendline
Gossamer Bio Faces Class Action Lawsuit Over Alleged Concealment of Placebo Risk
Gossamer Bio Faces Class Action Lawsuit Over Alleged Concealment of Placebo Risk
Read More
Trendline
Commvault Faces Securities Class Action Over Misleading ARR Growth Projections
Commvault Faces Securities Class Action Over Misleading ARR Growth Projections
Read More
Trendline
Vyome Holdings Reports Q1 2026 Financial Results with Net Loss
Vyome Holdings Reports Q1 2026 Financial Results with Net Loss
Read More
Trendline
Faruqi Faruqi, LLP Reminds Commvault Investors of Class Action Deadline Amid Allegations of Misleading Financial Projections
Faruqi Faruqi, LLP Reminds Commvault Investors of Class Action Deadline Amid Allegations of Misleading Financial Projections
Read More
Trendline
Rosen Law Firm Urges Immutep Ltd. Investors to Act Before Securities Class Action Deadline
Rosen Law Firm Urges Immutep Ltd. Investors to Act Before Securities Class Action Deadline
Read More
Trendline
Vyome Holdings Reports Q1 2026 Financial Results with Net Loss and Strategic Developments
Vyome Holdings Reports Q1 2026 Financial Results with Net Loss and Strategic Developments
Read More
Trendline
Vyome Holdings Reports Q1 2026 Financial Results and Strategic Developments
Vyome Holdings Reports Q1 2026 Financial Results and Strategic Developments
Read More
Trendline
Vyome Holdings Reports Q1 2026 Financial Results, Highlights Regulatory and Clinical Progress
Vyome Holdings Reports Q1 2026 Financial Results, Highlights Regulatory and Clinical Progress
Read More